Your shopping cart is currently empty

HER2-IN-15 (Compound 1) is a HER2 inhibitor that effectively targets the YVMA HER2 exon 20 insertion mutation (HER2 YVMA) with an IC50 of less than 200 nM. It also inhibits the proliferation of BaF3 cells with the HER2 YVMA mutation, achieving an IC50 of under 200 nM, and contributes to the improvement of non-small cell lung cancer (NSCLC).
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | HER2-IN-15 (Compound 1) is a HER2 inhibitor that effectively targets the YVMA HER2 exon 20 insertion mutation (HER2 YVMA) with an IC50 of less than 200 nM. It also inhibits the proliferation of BaF3 cells with the HER2 YVMA mutation, achieving an IC50 of under 200 nM, and contributes to the improvement of non-small cell lung cancer (NSCLC). |
| Targets&IC50 | Her2 exon 20 YVMA insertion:<200 nM |
| Formula | C28H29N9O2 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.